NANCY STALEY: Open Payments
NPI 1891758181 · WESTERLY, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,027 in 226 payments from 20 companies in 2025. Trend: 2023 $4,425 · 2024 $3,465 · 2025 $4,027
Food & beverage: $3,963Education: $65
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 25 | $725 |
| Janssen Biotech, Inc. | 30 | $537 |
| ABBVIE INC. | 38 | $493 |
| UCB, Inc. | 12 | $346 |
| Arcutis Biotherapeutics, Inc. | 20 | $282 |
| Incyte Corporation | 16 | $257 |
| Novartis Pharmaceuticals Corporation | 15 | $257 |
| E.R. Squibb & Sons, L.L.C. | 6 | $255 |
| PFIZER INC. | 25 | $190 |
| Galderma Laboratories, L.P. | 10 | $161 |
Products named: ADBRY, TREMFYA, Bimzelx, Zoryve, OPZELURA, Sotyktu, RINVOQ, SKYRIZI.
Industry payments across RI — which companies pay providers there.
